Showing 1,421 - 1,440 results of 32,320 for search '(( e point decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.99s Refine Results
  1. 1421
  2. 1422
  3. 1423

    S2 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  4. 1424

    S1 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  5. 1425
  6. 1426
  7. 1427

    Heteroplasmy evolution of cybrid clone V_50. by Anton K. Raap (109844)

    Published 2012
    “…<p>(A) Average cellular mutation load decreases with increasing passage number of clone V_50. …”
  8. 1428
  9. 1429

    Loneliness at 50+: The role of demographic and socioeconomic factors. by Sophie Guthmuller (9955408)

    Published 2022
    “…<p>Note: The figure displays odds ratios of individual socioeconomic and demographic variables at age 50+ for three different specifications. Specification (3) includes D, a set of individual socioeconomic and demographic variables at age 50+; P, a vector of the five scores of personality traits (extraversion, agreeableness, conscientiousness, neuroticism, openness); C, a vector of childhood circumstances (wealth; health; quality of the relationship with mother, father, and friends; importance of religion), and I, country-specific fixed effects. …”
  10. 1430

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…We report the synthesis and characterization of 14 complexes of the type (Au(R)[N̂N])<sup>+</sup>, where R = tunable biaryldialkyl phosphine ligands and [N̂N] = bidentate phenanthroline derivatives as anticancer agents. …”
  11. 1431
  12. 1432
  13. 1433
  14. 1434
  15. 1435
  16. 1436
  17. 1437
  18. 1438
  19. 1439
  20. 1440